✦ LIBER ✦

Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience

✍ Scribed by Ashok Jain; Rajeev Sharma; Charlotte Ryan; Saman Safadjou; Randeep Kashyap; Parvez Mantry; Benedict Maliakkal; Mark Orloff

Book ID: 110890104
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 218 KB
Volume: 24
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2009.00961.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained viral response to interferon a

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C

✍ Manal F. Abdelmalek; Roberto J. Firpi; Consuelo Soldevila-Pico; Alan I. Reed; Al 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 1 views

Recurrent hepatitis C infection is an important cause of progressive fibrosis, cirrhosis, and graft loss following orthotopic liver transplantation. Treatment for posttransplant recurrence of hepatitis C with interferon-based therapy is difficult but results in loss of detectable virus in up to 30%

Antiviral Therapy for Hepatitis C Virus

Antiviral Therapy for Hepatitis C Virus Recurrence Following Liver Transplantation: Long-Term Results From a Single Center Experience

✍ P. Burra; S. Targhetta; S. Pevere; S. Boninsegna; M. Guido; D. Canova; A. Broles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Efficacy, predictors of response, and po

Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C

✍ Marina Berenguer; Antonio Palau; Alberto Fernandez; Salvador Benlloch; Victoria 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

There are unresolved issues regarding sustained virological response (SVR), tolerance and risk of rejection following antiviral therapy in liver transplantation (LT). The aim of our study was to determine efficacy, rejection risk and factors associated with SVR. HCV-infected LT patients with at leas

8 Cadaveric liver allograft versus livin

8 Cadaveric liver allograft versus living donor allograft for hepatitis C viral infection in 100 consecutive liver transplant recipients under tacrolimus: Single center experience

✍ A. Bozorgzadeh; A. Jain; C. Ryan; D. Ornt; M. Zand; P. Mantry; K. Lansing; M. Or 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Flexible and individualized treatment to

Flexible and individualized treatment to achieve sustained viral response for recurrent hepatitis C in liver transplant recipients

✍ W.-C. Lee; T.-J. Wu; H.-S. Chou; C.-F. Lee; K.-M. Chan; S.-S. Cheng 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Long-term histological effects of preemp

Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection

✍ Alexander Kuo; Vivian Tan; Billy Lan; Mandana Khalili; Sandy Feng; John P. Rober 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

The long-term effects of preemptive antiviral therapy on fibrosis progression in liver transplant recipients with hepatitis C virus (HCV) were examined in a cohort of consecutive liver transplant recipients who received preemptive antiviral therapy for 48 weeks (95% were virologic nonresponders). Co